Clinical Trial Matcher

NCT06771427

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

Recruiting · Not specified · Taipei Veterans General Hospital, Taiwan · registry updated 2025-01-17

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.

Inclusion

  • Inclusion Criteria: aged between 20 and 75 years Schirmer's test less than 10 mm/5 min

Exclusion

  • Exclusion Criteria: Pregnancy With eye inflammation or infectious eye disease Accepted operation of eye Sjögren's syndrome
  • Inclusion Criteria: primary or secondary SS aged between 20 and 75 years fulfilled the 2002 American-European Consensus Criteria for SS (AECG) had no abnormal findings of immune, liver, kidney, or blood function evaluations.
  • Exclusion Criteria: a history of alcohol abuse, diabetes mellitus, or major life-threatening condition pregnancy or breastfeeding steroid pulse therapy within three months prior to the commencement of our study.
  • non AIDDES Healthy Controls
  • Inclusion Criteria: aged between 20 and 75 years without any Chronic disease Exclusion Criteria: any Sjögren's syndrome or Dry eye syndrome.

Open NCT06771427 on ClinicalTrials.govAll conditions